General Causation

General Causation

General Causation

General causation asks whether the agent can cause the condition in humans at relevant exposure levels. Proof relies on epidemiology, toxicology, animal studies, and mechanistic evidence.

It is a threshold requirement, and failure to establish it defeats every claim in the litigation regardless of individual circumstances.

Alternative Names:

General Causation Evidence, Capability Causation

Why it Matters?

This is the single most consequential issue in toxic tort and pharmaceutical litigation because it operates at the inventory level. A successful general causation challenge ends thousands of cases at once, which is why MDL courts often sequence it first through a dedicated Daubert track. Defense investment in epidemiology and methodology critique at this stage carries leverage no case-specific defense can match.

Frequently asked questions

What evidence establishes general causation?

What evidence establishes general causation?

Epidemiological studies showing association, supported by toxicology, dose-response data, biological plausibility, and consistency across studies.

Why is it litigated first?

Why is it litigated first?

Because it applies to every claim in the inventory. A defense win ends the entire litigation, while a plaintiff win still leaves individual causation to be proven.